Literature DB >> 1909642

Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells.

E Hermann1, A W Lohse, R Van der Zee, W Van Eden, W J Mayet, P Probst, T Poralla, K H Meyer zum Büschenfelde, B Fleischer.   

Abstract

Humoral and cellular immune reactions to heat-shock proteins have been implicated in the pathogenesis of arthritis. Heat-shock proteins occur in bacteria as well as all eukaryotes and have been highly conserved during evolution. Cross-reactivity between bacterial and human heat-shock proteins induced at the site of inflammation may underlie the pathogenesis of some forms of arthritis. In order to test this hypothesis, we raised and cloned a Yersinia-specific T cell line from the synovial fluid lymphocytes of a patient with Yersinia-induced reactive arthritis. From this line we obtained a CD4+ T cell clone that proliferated in response to Yersinia antigens and both to the mycobacterial and the human 65-kDa heat-shock protein. This T cell clone also proliferated in response to autologous heat-stressed antigen-presenting cells as well as to synovial fluid mononuclear cells from the inflamed joint, thus showing true autoreactivity against endogenously synthetized self-antigen. These results demonstrate the induction of an autoimmune T cell response by a natural bacterial infection and support the important role of heat-shock proteins in the pathogenesis of immune-mediated arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909642     DOI: 10.1002/eji.1830210923

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

Review 1.  The cellular immune response to heat shock proteins.

Authors:  S H Kaufmann
Journal:  Experientia       Date:  1992-07-15

Review 2.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

Review 3.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Clinical role for a superantigen in Yersinia pseudotuberculosis infection.

Authors:  J Abe; M Onimaru; S Matsumoto; S Noma; K Baba; Y Ito; T Kohsaka; T Takeda
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Modulation of adjuvant arthritis in Lewis rats by recombinant vaccinia virus expressing the human 60-kilodalton heat shock protein.

Authors:  J A López-Guerrero; J P López-Bote; M A Ortiz; R S Gupta; E Páez; C Bernabeu
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 7.  Molecular mimicry: any role in the pathogenesis of spondyloarthropathies?

Authors:  R Lahesmaa; M Skurnik; P Toivanen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

8.  Stimulation of synovial fluid mononuclear cells with the human 65-kD heat shock protein or with live enterobacteria leads to preferential expansion of TCR-gamma delta+ lymphocytes.

Authors:  E Hermann; A W Lohse; W J Mayet; R van der Zee; W Van Eden; P Probst; T Poralla; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 9.  Role of heat shock proteins in protection from and pathogenesis of infectious diseases.

Authors:  U Zügel; S H Kaufmann
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 10.  Rheumatoid arthritis: how well do the theories fit the evidence?

Authors:  J McCulloch; P M Lydyard; G A Rook
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.